Symbols

TNYA

Tenaya Therapeutics·NASDAQ

--(--)

TNYA Profile

Tenaya Therapeutics, Inc.

A clinical-stage biotech company that develops gene therapies for rare genetic disorders

Industry

Biological Technology

Established Date

Listing Date

07/30/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.tenayatherapeutics.com

Security Type

Common stock

Office address

171 Oyster Point Boulevard Suite 500 South San Francisco CA 94080

Business

Introduction

Tenaya Therapeutics, Inc., was incorporated in Delaware in August 2016. The company is a preclinical stage biotechnology company focused on discovering, developing and delivering treatments for the underlying drivers of heart disease. The company is advancing product candidates from three distinct but interrelated product platforms: gene therapy, cell regeneration and precision medicine.